Cart
sales@molnova.com
Deferitrin
CAS No. 239101-33-8
Deferitrin( GT-56-252 | GT 56 252 | GT-56252 | GT 56252 | Deferitrin )
Catalog No. M24099 CAS No. 239101-33-8
Deferitrin is an iron chelator. It potentially for the treatment of thalassemia and iron overload.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 672 | In Stock |
|
| 50MG | 888 | In Stock |
|
| 100MG | 1242 | In Stock |
|
| 500MG | 2502 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDeferitrin
-
NoteResearch use only, not for human use.
-
Brief DescriptionDeferitrin is an iron chelator. It potentially for the treatment of thalassemia and iron overload.
-
DescriptionDeferitrin is an iron chelator. It potentially for the treatment of thalassemia and iron overload.(In Vitro):The iron-clearing efficiency (ICE) of Deferitrin (GT-56-252) in a non-iron-overloaded rodent model after oral (po) administration at 300 μmol/kg is shown to be 1.1%.
-
In VitroThe iron-clearing efficiency (ICE) of Deferitrin (GT-56-252) in a non-iron-overloaded rodent model after oral (po) administration at 300 μmol/kg is shown to be 1.1%.
-
In Vivo——
-
SynonymsGT-56-252 | GT 56 252 | GT-56252 | GT 56252 | Deferitrin
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number239101-33-8
-
Formula Weight253.27
-
Molecular FormulaC11H11NO4S
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble
-
SMILESO=C([C@]1(C)N=C(C2=CC=C(O)C=C2O)SC1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bergeron RJ, Wiegand J, Bharti N, McManis JS, Singh S. Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicity. Biometals. 2011 Apr;24(2):239-58. Central PMCID: PMC3329216.
molnova catalog
related products
-
Roemerine
Roemerine is a potential active xanthine oxidase(XOD) inhibitor, XOD is a key enzyme in the pathogenesis of hyperuricemia and also a well-known target for the drug development to treat gout.
-
BR-1
BR-1 is a phosphatase of regenerating liver 3 (PRL-3) inhibitor which blocks the migration and invasion of metastatic cancer cells.
-
KRN5
KRN5 has potential to treat NFAT5-mediated Chronic Arthritis. KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC50 of 750 nM.
